Skip to menu Skip to content Skip to footer

2021

Conference Publication

Targeting FGFR2c isoform, a novel therapeutic target with FGFR inhibitor in endometrial cancer

Sengal, Asmerom T., Bonazzi, Vanessa, Kondrashova, Olga, Perrin, Lewis, Chetty, Naven, Smith, Deborah, Gil-Moreno, Antonio, Colas, Eva and Pollock, Pamela M. (2021). Targeting FGFR2c isoform, a novel therapeutic target with FGFR inhibitor in endometrial cancer. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1535-7163.TARG-21-LBA020

Targeting FGFR2c isoform, a novel therapeutic target with FGFR inhibitor in endometrial cancer

2021

Conference Publication

FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer

Sengal, Asmerom, Smith, Deborah, Rogers, Rebecca, Snell, Cameron, Williams, Elizabeth and Pollock, Pamela (2021). FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer. AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, Electr Network, Nov 09-10, 2020. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer

2021

Conference Publication

FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer

Sengal, Asmerom, Smith, Deborah, Rogers, Rebecca, Snell, Cameron, Williams, Elizabeth and Pollock, Pamela (2021). FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer. AACR Virtual Special Conference: Endometrial Cancer: New Biology Driving Research and Treatment, Virtual, 9-10 November 2020. Philadelphia, PA USA: American Association for Cancer Research. doi: 10.1158/1557-3265.endomet20-po033

FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer

2021

Conference Publication

Genomic characterization of endometrial cancer patient-derived xenografts reveals intratumor heterogeneity

Kondrashova, Olga, Bonazzi, Vanessa F., Smith, Deborah, Nones, Katia, Sengal, Asmerom, Ju, Robert, Packer, Leisl M., Koufariotis, Lambros T., Kazakoff, Stephen H., Davidson, Aimee L., Ramarao-Milne, Priya, Lakis, Vanessa, Newell, Felicity, Rogers, Rebecca, Davies, Claire, Chetty, Naven, Perrin, Lewis, Pearson, John, Patch, Ann-Marie, Garrett, Andrea, Waddell, Nicola, Pollock, Pamela and Nicklin, James (2021). Genomic characterization of endometrial cancer patient-derived xenografts reveals intratumor heterogeneity. AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, Electr Network, Nov 09-10, 2020. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

Genomic characterization of endometrial cancer patient-derived xenografts reveals intratumor heterogeneity